Oncopro Liquid Biopsy Test sale cost 38610 AED
Oncopro PD-L1 Circulating Tumor Cells Test sale cost 9880 AED Oncopro PD-L1 Circulating Tumor Cells Test 12,000 د.إ Original price was: 12,000 د.إ.9,880 د.إCurrent price is: 9,880 د.إ.
Sale!

Oncopro Liquid Biopsy Test

Original price was: 42,900 د.إ.Current price is: 38,610 د.إ.

-10%

The Oncopro Liquid Biopsy Test is a cutting-edge diagnostic tool offered by DNA Labs UAE, designed to detect and monitor various types of cancers through a non-invasive method. This innovative test requires only a blood sample from the patient, making it a less intrusive option compared to traditional biopsy methods that require tissue samples. The liquid biopsy technique focuses on analyzing circulating tumor DNA (ctDNA) present in the blood, which sheds from the tumor, allowing for the identification of genetic mutations and alterations associated with cancer.

With a cost of 38,610 AED, the Oncopro Liquid Biopsy Test represents a significant investment in personal health care, offering a valuable resource for early detection, treatment planning, and monitoring of cancer progression or response to treatment. The test is particularly beneficial for patients who are unable to undergo conventional biopsy procedures due to health constraints or for cancers that are difficult to access. By providing detailed insights into the molecular profile of a patient’s cancer, the Oncopro Liquid Biopsy Test enables personalized treatment strategies, potentially improving outcomes and quality of life for cancer patients.

DNA Labs UAE, as the provider of this test, underscores its commitment to leveraging advanced genetic testing technologies to support cancer care. The test is part of a broader movement towards precision medicine, where treatments can be tailored to the individual characteristics of each patient’s disease, offering a more targeted and effective approach to cancer treatment.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ONCOPRO LIQUID BIOPSY Test

Cost: AED 38610.0

Symptoms, Diagnosis, and Test Details

The ONCOPRO LIQUID BIOPSY Test is a non-invasive diagnostic test used to detect cancer by analyzing circulating tumor DNA (ctDNA) present in a patient’s blood sample. The test is used to monitor the progression of cancer, identify potential drug resistance, and determine the best treatment options for the patient.

The ONCOPRO LIQUID BIOPSY Test consists of a 73 Gene Panel with MSI, including genes such as ABL1, AKT1, ALK, APC, AR, ARID1A, ATM, BRAF, CDH1, CDKN2A, CSF1R, CTCF, CTNNB1, DNMT3A, EGFR, EP300, EPHA3, EPHA5, ERBB2, ERBB4, EZH2, FBXW7, FGFR1, FGFR2, FGFR3, FLT3, GATA3, GNA11, GNAQ, GNAS, HNF1A, HRAS, IDH1, IDH2, JAK2, JAK3, KDR, KEAP1, KIT, KRAS, LIFR, MAP2K1, MAP3K1, MET, MLH1, MPL, MTOR, NAV3, NFE2L2, NOTCH1, NPM1, NRAS, PDGFRA, PIK3CA, PIK3R1, PTCH1, PTEN, PTPN11, RB1, RUNX1, SETD2, SMAD2, SMAD4, SMARCA4, SMARCB1, SMO, SRC, STK11, TP53, VHL, ROS1, BRCA2, and BRCA1.

The ONCOPRO LIQUID BIOPSY Test is a highly sensitive and specific test that can detect even small amounts of ctDNA, making it a valuable tool for early cancer detection and personalized cancer treatment. The test is minimally invasive and can be performed on an outpatient basis, making it convenient for patients.

Test Information

  • Price: AED 38610.0
  • Sample Condition: 20 mL whole blood in 2 Streck tubes available from LPL. Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE.
  • Report Delivery: Sample daily by 9 am; Report 35 working days
  • Method: Next Generation Sequencing
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Molecular Diagnostics
  • Pre Test Information: Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32) is mandatory.

The ONCOPRO LIQUID BIOPSY Test is a promising new technology that has the potential to revolutionize cancer diagnosis and treatment.

Test Name ONCOPRO LIQUID BIOPSY Test
Components 73 Gene Panel with MSI: *ABL1, *AKT1, *ALK, *APC, *AR, *ARID1A, *ATM, *BRAF, *CDH1, *CDKN2A, *CSF1R, *CTCF, *CTNNB1, *DNMT3A, *EGFR, *EP300, *EPHA3, *EPHA5, *ERBB2, *ERBB4, *EZH2, *FBXW7, *FGFR1, *FGFR2, *FGFR3, *FLT3, *GATA3, *GNA11, *GNAQ, *GNAS, *HNF1A, *HRAS, *IDH1, *IDH2, *JAK2, *JAK3, *KDR, *KEAP1, *KIT, *KRAS, *LIFR, *MAP2K1, *MAP3K1, *MET, *MLH1, *MPL, *MTOR, *NAV3, *NFE2L2, *NOTCH1, *NPM1, *NRAS, *PDGFRA, *PIK3CA, *PIK3R1, *PTCH1, *PTEN, *PTPN11, *RB1, *RUNX1, *SETD2, *SMAD2, *SMAD4, *SMARCA4, *SMARCB1, *SMO, *SRC, *STK11, *TP53, *VHL, *ROS1, *BRCA2, *BRCA1
Price 38610.0 AED
Sample Condition 20 mLwhole bloodin 2 Streck tubes available from LPL. Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32)is mandatory.
Report Delivery Sample Daily by 9 am; Report 35 Working days
Method Next Generation Sequencing
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32)is mandatory.
Test Details

ONCOPRO Liquid Biopsy Test is a non-invasive diagnostic test used to detect cancer by analyzing circulating tumor DNA (ctDNA) present in a patient’s blood sample. The test is used to monitor the progression of cancer, identify potential drug resistance, and determine the best treatment options for the patient. The ONCOPRO Liquid Biopsy Test is a highly sensitive and specific test that can detect even small amounts of ctDNA, making it a valuable tool for early cancer detection and personalized cancer treatment. The test is minimally invasive and can be performed on an outpatient basis, making it convenient for patients. The ONCOPRO Liquid Biopsy Test is a promising new technology that has the potential to revolutionize cancer diagnosis and treatment.

SKU: TEST-670 Category:

Related products